Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.38 |
| ▸ | NOS1 | P29475 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 7/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.35 |
| ▸ | MEN1 | O00255 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | HBB | P68871 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368694 | 0.80 | EPHX1 (0.47) | ALDH1A1MAPK1TDP1MEN1KMT2A | |
| SCHEMBL29289210 | 0.78 | HTR2A (0.41) | SIGMAR1SLC6A2ADORA1SLC6A3EPHX1 | |
| SCHEMBL24815612 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TRPA1MAPK1TDP1MEN1 | |
| SCHEMBL15261382 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TRPA1MAPK1TDP1MEN1 | |
| SCHEMBL10438321 | 0.74 | ALDH1A1 (0.44) | NOS3NOS1NOS2ALDH1A1TRPA1 | |
| SCHEMBL5324683 | 0.73 | TAAR1 (0.45) | KMT2ASIGMAR1CYP3A4SLC6A2SLC6A3 | |
| SCHEMBL11881831 | 0.72 | CYP3A4 (0.51) | ALDH1A1TRPA1MAPK1TDP1MEN1 | |
| SCHEMBL368692 | 0.72 | ALDH1A1 (0.38) | NOS3NOS1NOS2ALDH1A1TRPA1 | |
| SCHEMBL16100132 | 0.71 | CYP3A4 (0.46) | ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL21524964 | 0.71 | ALDH1A1 (0.50) | ALDH1A1TRPA1MAPK1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107573326-B | Novel benzotriazole derivative and organic electroluminescent device using the same | 保土谷化学工业株式会社 | 2024-03-15 | — | — | CN | disclosed |
| EP-3432688-B1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2023-12-20 | — | — | EP | disclosed |
| CN-112079814-B | Benzotriazole derivative and organic electroluminescent device | 保土谷化学工业株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-11056653-B2 | Organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2021-07-06 | — | — | US | disclosed |
| CN-112079814-A | Benzotriazole derivative and organic electroluminescent device | 保土谷化学工业株式会社 | 2020-12-15 | — | — | CN | disclosed |
| US-20200328353-A1 | Organic Electroluminescence Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| EP-2767534-B1 | NEW BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IN WHICH SAID DERIVATIVE IS USED | HODOGAYA CHEMICAL CO LTD (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-3432688-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2019-01-23 | — | — | EP | disclosed |
| EP-2409974-B1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-9842999-B2 | Benzotriazole derivative and an organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2017-12-12 | — | — | US | disclosed |
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
| EP-3029034-A1 | BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-9005776-B2 | Compound having benzotriazole ring structure and organic electroluminescent element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-04-14 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
| EP-2767534-A1 | NEW BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IN WHICH SAID DERIVATIVE IS USED | Hodogaya Chemical Co., Ltd. (JP) | 2014-08-20 | — | — | EP | disclosed |
| EP-2409974-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SHINSHU UNIVERSITY (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164001-A1 | A BENZOTRIAZOLE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT DEVICE | AHR, ARNT, NAT1 | NOS3 4413/4885NOS1 3422/4885NOS2 3731/4885 |
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | BRD4, ARNT, MLLT1 | NOS3 2705/4885NOS1 2540/4885NOS2 2548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.